Atul Pande, M.D
Atul Pande has a broad experience in strategic enterprise leadership of R&D with proven results as demonstrated by successful regulatory filings and approvals of new drugs.
Dr. Pande has experience in Neurosciences, Respiratory, HIV, Oncology and Cardiovascular therapy areas.
Suggested For You
webinar
August 28th, 2025
Shaping the Future of AI-Enabled Medical Writing
perspectives
July 29th, 2025
Why Quality by Design Is Still Underused in Emerging Biotech, and What Can Be Done About It
perspectives
July 22nd, 2025
Career Insights: From Military Service to Regulatory Strategy – Ritchie Patton’s Journey at MMS
regulatory intelligence
July 16th, 2025
Navigating the National Priority Review Voucher: Challenges and Solutions
perspectives
July 15th, 2025
Smart AI, Smarter Oversight: What Sponsors Really Need from Their CRO
perspectives
July 8th, 2025
Guidance for Working with External Data Vendors – Getting from LPLV to Database Lock Faster
perspectives
July 1st, 2025
Why Real-Time Data Access Matters (and How to Make the Most of It)
webinar
July 31st, 2025
Design, Data, and Decisions in Oncology Trials
perspectives
June 24th, 2025
Why Now Is the Time for Specialized, Data-Focused CRO Partners
news
June 19th, 2025
MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion
perspectives
June 17th, 2025
Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise
regulatory intelligence
June 16th, 2025
Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting